(Q35572870)

8 August 2017

1 reference

title

The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans (English)

1 reference

8 August 2017

1 reference

Hooper DC

1

1 reference

PubMed ID

2936302

8 August 2017

Wolfson JS

series ordinal

2

1 reference

PubMed ID

2936302

8 August 2017

language of work or name

English

0 references

publication date

1 November 1985

1 reference

Antimicrobial Agents and Chemotherapy

8 August 2017

1 reference

8 August 2017

28

1 reference

8 August 2017

716-721

1 reference

8 August 2017

5

1 reference

Urinary tract antiseptics

8 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176369

Treatment of uncomplicated gonorrhea with rosoxacin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176369

Pharmacokinetics and tissue penetration of ciprofloxacin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176369

Penetration of pefloxacin into cerebrospinal fluid of patients with meningitis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176369

Pharmacokinetics and tissue penetration of enoxacin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176369

Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humans

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176369

In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176369

Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176369

Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176369

Pharmacokinetics of intravenously administered ciprofloxacin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176369

A double blind study comparing two dosages of enoxacin for the treatment of uncomplicated urogenital gonorrhoea.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176369

Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176369

Treatment of Penicillin-ResistantNeisseria gonorrhoeaewith Oral Norfloxacin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176369

The treatment of Pseudomonas aeruginosa urinary tract infections with norfloxacin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176369

Norfloxacin--a review of pharmacology and tissue penetration

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176369

Norfioxacin (MK–0366) treatment of urinary tract infections in hospitalized patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176369

Norfloxacin-induced rheumatic disease.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176369

Mechanism of renal excretion of AM-715, a new quinolonecarboxylic acid derivative, in rabbits, dogs, and humans

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176369

Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176369

Pharmacokinetics of ciprofloxacin after oral and parenteral administration

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176369

Comparison of high-pressure liquid chromatography and bioassay for determination of ciprofloxacin in serum and urine

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176369

Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176369

Multiclinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urinary tract infections

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176369

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176369

Comparative study using norfloxacin and amoxycillin in the treatment of complicated urinary tract infections in geriatric patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176369

Treatment of simple urinary tract infections in general practice with a 3-day course of norfloxacin

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176369

Norfloxacin disposition after sequentially increasing oral doses

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176369

Enoxacin raises plasma theophylline concentrations

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176369

Treatment of acute urinary infection by norfloxacin or nalidixic acid/citrate: a multi-centre comparative study

26 September 2018

1 reference

12 December 2020

Quinolones and raised plasma concentrations of theophylline

1 reference

12 December 2020

Pharmacokinetic Studies of Norfloxacin in Laboratory Animals

1 reference

12 December 2020

Dose- and sex-independent disposition of ciprofloxacin

1 reference

12 December 2020

Pharmacokinetics of norfloxacin in renal failure

1 reference

12 December 2020

The clinical pharmacokinetics and tolerance of enoxacin in healthy volunteers

1 reference

12 December 2020

Pharmacokinetics and tolerance of enoxacin in healthy volunteers administered at a dosage of 400 mg twice daily for 14 days

1 reference

12 December 2020

Serum and sputum concentrations of enoxacin after single oral dosing in a clinical and bacteriological study

1 reference

12 December 2020

Dose-dependent pharmacokinetic study of pefloxacin, a new antibacterial agent, in humans

1 reference

12 December 2020

Multiple-dose ciprofloxacin kinetics in normal subjects

1 reference

12 December 2020

Intraprostatic concentration of ciprofloxacin and its activity against urinary pathogens

1 reference

12 December 2020

The pharmacokinetics and tissue penetration of ofloxacin

1 reference

12 December 2020

Ciprofloxacin distribution in prostatic tissue and fluid following oral administration

1 reference

12 December 2020

Bactericidal intraprostatic concentrations of norfloxacin

1 reference

12 December 2020

Pharmacokinetics of norfloxacin in healthy volunteers and patients with renal and hepatic damage

1 reference

12 December 2020

Clinical evaluation of norfloxacin versus cotrimoxazole in urinary tract infections

1 reference

12 December 2020

Norfloxacin versus cotrimoxazole in the treatment of lower urinary tract infections

1 reference

12 December 2020

Norfloxacin in acute urinary tract infections

1 reference

12 December 2020

The pharmacokinetics and tissue penetration of norfloxacin

1 reference

12 December 2020

Norfloxacin versus cotrimoxazole in the treatment of uncomplicated urinary tract infections--a multi-centre trial

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.28.5.716

1 reference

8 August 2017

1 reference

8 August 2017

1 reference

PubMed ID

2936302